Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Quality of life in the Canadian Implantable Defibrillator Study (CIDS).
Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ.
Am Heart J. 2002 Aug;144(2):282-9.
Similar articles
Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH).
Oseroff O, Retyk E, Bochoeyer A.
Curr Opin Cardiol. 2004 Jan;19(1):26-30. Review.
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A, Husser D, Cannom DS.
Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.
Role of amiodarone in the era of the implantable cardioverter defibrillator.
Dorian P, Mangat I.
J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S78-81. Review.
Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review.
Ferreira-González I, Dos-Subirá L, Guyatt GH.
Eur Heart J. 2007 Feb;28(4):469-77. Epub 2007 Jan 16. Review.
Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM Jr.
J Am Coll Cardiol. 2009 Nov 24;54(22):1993-2000. doi: 10.1016/j.jacc.2009.07.039. Review.
Quality of life and psychological status of patients with implantable cardioverter defibrillators.
Thomas SA, Friedmann E, Kao CW, Inguito P, Metcalf M, Kelley FJ, Gottlieb SS.
Am J Crit Care. 2006 Jul;15(4):389-98. Review.
Quality of life and psychological impact of implantable cardioverter defibrillators: focus on randomized controlled trial data.
McCready MJ, Exner DV.
Card Electrophysiol Rev. 2003 Jan;7(1):63-70. Review.
The impact of the implantable cardioverter defibrillator on quality of life.
Gallagher RD, McKinley S, Mangan B, Pelletier D, Squire J, Mitten-Lewis S.
Am J Crit Care. 1997 Jan;6(1):16-24. Review.
Emotional distress in partners of patients with an implantable cardioverter defibrillator: a systematic review and recommendations for future research.
Van Den Broek KC, Habibović M, Pedersen SS.
Pacing Clin Electrophysiol. 2010 Dec;33(12):1442-50. doi: 10.1111/j.1540-8159.2010.02885.x. Epub 2010 Oct 14. Review.
Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
Eckardt L, Breithardt G.
Heart Rhythm. 2006 Apr;3(4):484-7. Epub 2006 Feb 28. Review. No abstract available.
Nonpharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials.
Saksena S, Breithardt G, Dorian P, Greene HL, Madan N, Block M.
Prog Cardiovasc Dis. 1996 May-Jun;38(6):429-44. Review.
Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question?
Josephson M, Nisam S.
Am J Cardiol. 1996 Apr 15;77(10):859-63. Review. No abstract available.
[Fundamental principle in therapy for arrhythmia].
Atarashi H.
Nihon Naika Gakkai Zasshi. 2006 Feb 10;95(2):228-33. Review. Japanese. No abstract available.
Factors influencing psychological status and quality of life in patients with implantable cardioverter-defibrillators.
Kajanová A, Bulava A, Eisenberger M.
Neuro Endocrinol Lett. 2014;35 Suppl 1:54-8. Review.
Supportive communication with implantable cardioverter defibrillator patients: seven principles to facilitate psychosocial adjustment.
Eads AS, Sears SF Jr, Sotile WM, Conti JB.
J Cardiopulm Rehabil. 2000 Mar-Apr;20(2):109-14. Review.
Living with an implantable cardioverter defibrillator: impact on the patient, family, and society.
Ocampo CM.
Nurs Clin North Am. 2000 Dec;35(4):1019-30. Review.
Cognitive therapy for ventricular dysrhythmia patients.
Dunbar SB, Summerville JG.
J Cardiovasc Nurs. 1997 Oct;12(1):33-44. Review.
Implantable cardioverter-defibrillators.
Connelly DT.
Heart. 2001 Aug;86(2):221-6. Review. No abstract available.
Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?
Pratt CM, Camm AJ, Bigger JT Jr, Breithardt G, Campbell RW, Epstein AE, Kappenberger LJ, Kuck K, Pocock S, Saksena S, Waldo AL.
Eur Heart J. 1999 Nov;20(21):1538-52. Review.
Filters: Manage Filters